iLite TLR9 Assay Ready Cells
iLite TLR9 Assay Ready Cells are Developed and Manufactured by Svar Life Science
The Eagle Biosciences iLite TLR9 Assay Ready Cells are intended for:
- Quantification of class B CpG oligonucleotides (LABEL-DOC-0572)
- Quantification of TLR9 inhibitor (LABEL-DOC-0579)
Content: 250 µL of Assay Ready Cells suspended in cryoprotective medium from Gibco
Receipt and Storage: Upon receipt confirm that adequate dry-ice is present, and the cells are frozen. Immediately transfer to -80°C storage. Cells should be stored at -80°C (do not store at any other temperature) and are stable as supplied until the expiry date shown. Cells should be used within 30 min of thawing and should be diluted immediately after thawing.
For Research Use Only
Key benefits of iLite Assays
- Highly specific reporter gene cell lines
- Very sensitive cell line responses (10 fold inductions)
- Assay Ready Cells – ready-to-use from the freezer, without culturing of cells
- Assays within a workday (typically 4-7 hour assays)
- Normalization gene, which eliminates unwanted matrix effects
Product Description
iLite TLR9 Assay Ready Cells are based on the human erythromyeloblastoid leukemia cell line (K562) and have been genetically engineered and optimized to be responsive to unmethylated CpG islands through Toll-like Receptor 9 (TLR9), resulting in a proportional expression of Firefly Luciferase. Normalization of cell counts and serum matrix effects are obtained by a second reporter gene, a Renilla Luciferase reporter gene construct, under the control of a constitutive promoter.
